Search Results - "Lum, Phillip"

Refine Results
  1. 1
  2. 2

    Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson by Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi

    Published in Journal for immunotherapy of cancer (11-05-2018)
    “…Immune checkpoint inhibitors (ICPIs) are gaining increasing popularity as an efficacious treatment for advanced malignancies. ICPI treatment can be complicated…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstruction by Weston, Brian R., Patel, Jigar M., Pande, Mala, Lum, Phillip J., Ross, William A., Raju, Gottumukkala S., Lynch, Patrick M., Coronel, Emmanuel, Ge, Phillip S., Lee, Jeffrey H.

    Published in Surgical endoscopy (01-08-2021)
    “…Background Previous studies evaluating self-expandable metal stents (SEMS) for management of malignant extrinsic colon obstruction have yielded conflicting…”
    Get full text
    Journal Article
  6. 6

    Dysphagia: An Unusual Presentation of Metastatic Uterine Cervical Carcinoma by Hameed, Anam, Dekovich, Alexander A, Lum, Phillip J, Shafi, Mehnaz A

    “…Worldwide, cervical cancer is the third most common cancer among women and the fourth leading cause of death from cancer. The most common sites of metastasis…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    447 Clinical Characteristics of Secondary Achalasia Associated With a Malignancy: A 20-Year Review From a Cancer Hospital by Shafi, Mehnaz A., Bokhari, Raza, Lum, Phillip, Stroehlein, John

    Published in The American journal of gastroenterology (01-10-2019)
    “…INTRODUCTION: Achalasia is an uncommon neurodegenerative disorder of esophageal motor function with an annual incidence of 1.6:100, 000. Most cases are…”
    Get full text
    Journal Article
  10. 10

    Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors by Tang, Tenglong, Abu-Sbeih, Hamzah, Luo, Wenyi, Lum, Phillip, Qiao, Wei, Bresalier, Robert S., Richards, David M., Wang, Yinghong

    Published in Scandinavian journal of gastroenterology (04-05-2019)
    “…Background: Immune checkpoint inhibitors (ICIs) have demonstrated effectiveness in treating many malignancies. Gastrointestinal (GI) adverse events are…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center by Angsuwatcharakon, Phonthep, Ahmed, Osman, Lynch, Patrick M., Lum, Phillip, Gonzalez, Graciella N., Weston, Brian, Coronel, Emmanuel, Katz, Matthew H.G., Folloder, Justin, Lee, Jeffrey H.

    Published in Gastrointestinal endoscopy (01-08-2020)
    “…The management of ampullary adenomas in familial adenomatous polyposis (FAP) is challenging due to multiple adenomas in the duodenum, history of previous major…”
    Get full text
    Journal Article